To date, very few studies have addressed nonneutropenic fever (NNF) in children with cancer, and there are no consensus guidelines. This scoping review aims to describe the rate of bacteremia, risk factors for infection and management, and outcomes of NNF in this population. Across 15 studies (n = 4106 episodes), the pooled-average bacteremia rate was 8.2%, and risk factors included tunneled external central venous catheter, clinical instability, and higher temperature. In two studies, antibiotics were successfully withheld in a subset of low-risk patients. Overall outcomes of NNF appear favorable; however, further research is required to determine its true clinical and economic impact.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.27634 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An unusual case of Herbaspirillum huttiense bacteraemia in a haemodialysis patient.
Nephrology (Carlton)
December 2024
Department of Medicine, University of Otago, Dunedin, New Zealand.
Article Synopsis
- Herbaspirillum spp. is a bacterium typically found in environments like soil and water, and is rarely linked to infections, especially in healthy individuals.
- A 57-year-old male with no neutropenia experienced symptoms like fever and malaise after undergoing home dialysis, leading to the discovery of Herbaspirillum huttiense in his blood cultures.
- After treating him with various antibiotics and removing his central line, he recovered without complications, raising the significance of this rare infection in a non-neutropenic dialysis patient.
The plasma viral communities associate with clinical profiles in a large-scale haematological patients cohort.
Microbiome
July 2024
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, 100044, China.
Background: Haematological patients exhibit immune system abnormalities that make them susceptible to viral infections. Understanding the relationship between the virome in the blood plasma of haematological patients and their clinical characteristic is crucial for disease management. We aimed to explore the presence of viral pathogens and identify close associations between viral infections and various clinical features.
View Article and Find Full Text PDFPredictors of radiographic pneumonia in febrile children with cancer presenting to the emergency department.
Arch Pediatr
August 2024
Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Children's Health Ireland, Temple Street, Dublin, Ireland. Electronic address:
Background: Fever is a common presenting complaint to the pediatric emergency department (PED), especially among oncology patients. While bacteremia has been extensively studied in this population, pneumonia has not. Some studies suggest that chest X-ray (CXR) does not have a role in the investigation of neutropenic fever in the absence of respiratory symptoms, yet non-neutropenic pediatric oncology patients were excluded from these studies.
View Article and Find Full Text PDFProspective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
J Clin Oncol
March 2024
Department of Pediatrics, Vanderbilt University Medical Center and the Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt-Ingram Cancer Center, Nashville, TN.
Purpose: The optimal management of fever without severe neutropenia (absolute neutrophil count [ANC] ≥500/µL) in pediatric patients with cancer is undefined. The previously proposed Esbenshade Vanderbilt (EsVan) models accurately predict bacterial bloodstream infections (BSIs) in this population and provide risk stratification to aid management, but have lacked prospective external validation.
Materials And Methods: Episodes of fever with a central venous catheter and ANC ≥500/µL occurring in pediatric patients with cancer were prospectively collected from 18 academic medical centers.
Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study.
Front Oncol
August 2023
The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, MD, United States.
Background: The efficacy of combination chemotherapy beyond the first-line setting remains modest in patients with advanced pancreatic adenocarcinoma (PAC). Evidence from recent clinical studies has shown that liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) resulted in survival benefits in patients with advanced pancreatic adenocarcinoma (APAC) after progression on gemcitabine-based treatment. However, the survival benefits of nal-IRI in the third and later lines, in which limited options are available, have yet to be extensively studied.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!